Biogen Inc/ US09062X1037 /
| 2024-04-26 10:00:00 PM | Chg. +6.4400 | Volume | Bid1:47:07 AM | Ask1:47:07 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 208.9000USD | +3.18% | 1.89 mill. Turnover: 240.5 mill. |
208.5000Bid Size: 100 | 209.0000Ask Size: 200 | 30.42 bill.USD | - | 26.05 |
Assets
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,742.2000 | 1,750.7000 | 1,765.6830 | 2,187.6000 | 2,501.8000 | ||||||
| Intangible Assets | 1,631.5000 | 4,474.7000 | 4,028.5070 | 4,085.1000 | 3,808.3000 | ||||||
| Long-Term Investments | 2,036.7000 | 625.8000 | 1,470.6520 | 2,760.4000 | 2,829.4000 | ||||||
| Fixed Assets | - | - | 9,643.8860 | 12,804.5000 | 14,144.6000 | ||||||
| Inventories | 447.4000 | 659 | 804.0220 | 893.4000 | 1,001.6000 | ||||||
| Accounts Receivable | 686.8000 | 824.4000 | 1,292.4450 | 1,227 | 1,441.6000 | ||||||
| Cash and Cash Equivalents | 570.7000 | 602.6000 | 1,204.9240 | 1,308 | 2,326.5000 | ||||||
| Current Assets | 3,244.3000 | 3,184.9000 | 4,672.6730 | 6,700.3000 | 8,732.2000 | ||||||
| Total Assets | 10,130.1000 | 11,863.3000 | 14,316.5590 | 19,504.8000 | 22,876.8000 | ||||||
Liabilities
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 204 | 219.9000 | 229.1780 | 267.4000 | 279.8000 | ||||||
| Long-term debt | - | 592.4000 | 582.0610 | 6,521.5000 | 6,512.7000 | ||||||
| Liabilities to Banks | 0.0000 | 592.4000 | 582.1000 | 6,521.5000 | 6,512.7000 | ||||||
| Provisions | 237.4000 | 412.3000 | 218.8000 | 333.6000 | 325 | ||||||
| Liabilities | 3,166.3000 | 3,242.5000 | 3,502.5190 | 10,129.9000 | 10,748.2000 | ||||||
| Share Capital | - | - | .1290 | .1000 | .1000 | ||||||
| Total Equity | 6,963.8000 | 8,620.8000 | 10,814.0400 | 9,374.9000 | 12,128.6000 | ||||||
| Minority Interests | 2.3000 | .6000 | 5.0300 | 2.1000 | -11.5000 | ||||||
| Total liabilities equity | 10,130.1000 | 11,863.3000 | 14,316.5590 | 19,504.8000 | 22,876.8000 | ||||||
Income Statement
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 5,516.5000 | 6,932.2000 | 9,703.3240 | 10,763.8000 | 11,448.8000 | ||||||
| Depreciation (total) | 202.2000 | 342.9000 | 688.1500 | 600.4000 | 682.7000 | ||||||
| Operating Result | 1,809.1000 | 2,490.6000 | 3,972.4140 | 4,891 | 5,150.4000 | ||||||
| Interest Income | - | - | -17.3000 | -73.4000 | -196.6000 | ||||||
| Income Before Taxes | 1,855.1000 | 2,480.6000 | 3,946.6330 | 4,767.3000 | 4,933 | ||||||
| Income Taxes | 470.6000 | 601 | 989.9420 | 1,161.6000 | 1,237.3000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 6.7810 | 46.2000 | -7.1000 | ||||||
| Net Income | 1,380 | 1,862.3000 | 2,934.7840 | 3,547 | 3,702.8000 | ||||||
Per Share
Cash Flow
| 2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,879.9000 | 2,345.1000 | 2,942.1150 | 3,716.1000 | 4,522.4000 | ||||||
| Cash Flow from Investing Activities | -950.3000 | -1,604.7000 | -1,542.9760 | -4,553.6000 | -2,484.8000 | ||||||
| Cash Flow from Financing | -877.5000 | -716.5000 | -755.8730 | 986.4000 | -987.8000 | ||||||
| Decrease / Increase in Cash | 52.1000 | 23.9000 | 643.2660 | 148.9000 | 1,049.8000 | ||||||
| Employees | 5,950 | 6,850 | 7,550 | 7,350 | 7,400 | ||||||
